Sumail, Baby Boy .
HRN: 23-89-96 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/29/2023
11/05/2023
IV
45mg
Q24
PSNB
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes